Pharmaron Beijing Co., Limited: Pharmaron's Liverpool UK Gene Therapy CDMO Commences Major Site Expansion Following UK Government Grant to Support £151m Investment

Building capacity in Gene Therapy Pharmaron Beijing Co., Limited (Stock Code: 300759.SZ/3759.HK) ("Pharmaron") announced today that their Liverpool, UK based Gene Therapy CDMO has received a prestigious

Related Keywords

United Kingdom ,China ,Ellen Cabral ,Boliang Lou ,Stock Code ,Nasdaq ,Therapeutics Ltd Ctx ,Pharmaron Beijing Co ,Allergan ,Gene Therapy ,United Kingdom Government ,Life Sciences Innovation Manufacturing Fund ,Chief Executive Officer ,Clinical Manufacture ,Geographic Atrophy ,Complement Therapeutics Ltd ,Senior Marketing Director Tel ,Pharmaron ,Beijing ,Imited ,Liverpool ,Gene ,Therapy ,Dmo ,Ommences ,Major ,Bite ,Expansion ,Following ,Government ,Rant ,Support ,R51m ,Investment ,